Novel Coronavirus (SARS-CoV-2/COVID-19)
America’s hospitals and health systems continue to face unprecedented financial pressures due to the ongoing effects of the COVID-19 pandemic and current inflationary economy. Historic inflation has extended and heightened the already severe economic instability brought on by the pandemic resulting…
The FDA last week revised its Evusheld fact sheet for health care providers, recommending repeat dosing every six months if patients need ongoing protection.
The Living Learning Network’s pandemic reflection book showcases the defining moments of COVID-19 as told by the front lines.
The AHA has been collecting resources to assist organizations in their efforts to plan for the future post-COVID-19 workforce.
Seattle Children’s Hospital is taking a collaborative approach with parents to vaccinate very young children against COVID-19
The Food and Drug Administration today announced it has revoked the emergency use authorizations for the Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test and Simoa SARS-CoV-2 N Protein Antigen Test.
The CDC endorsed Moderna’s COVID-19 vaccine for children aged 6-17.
All of America’s hospitals and health systems, regardless of size, location and ownership type have provided essential care to their patients and communities during this historic COVID-19 pandemic, all while facing tremendous financial challenges and pressures.
Dispensing rates of prescriptions for COVID-19 antiviral pills were lowest in the most socially and economically disadvantaged communities, according to a study released by the CDC.
The Food and Drug Administration Friday authorized the first COVID-19 test to identify and differentiate certain SARS-CoV-2 lineages in respiratory samples that test positive for the virus.